New Wegovy TV Commercial Launched After Pause to Deal with High Demand

Novo Nordisk has re-started promotion of its weight-loss drug Wegovy (semaglutide) with a new TV advertisement after halting promotional materials for the drug last May.

The promotional pause was made to manage the high demand for the weight loss injection. The demand was so overwhelming that the Danish drugmaker decided to stop advertising Wegovy “to avoid stimulating further demand.” The demand for the GLP-1 agonist has largely been fuelled by social media and celebrity endorsements.